Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27021150)
Watch
English
Quantitative phenotypic and pathway profiling guides rational drug combination strategies
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
title
Quantitative phenotypic and pathway profiling guides rational drug combination strategies
(English)
0 references
author
Neil O Carragher
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
author name string
John C Dawson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
language of work or name
English
1 reference
stated in
PubMed
publication date
2014
1 reference
stated in
PubMed
published in
Frontiers in Pharmacology
2 references
stated in
Crossref
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
volume
5
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
page(s)
118
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
cites work
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
21 March 2017
An unbiased cell morphology-based screen for new, biologically active small molecules
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
21 March 2017
A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
21 March 2017
A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
21 March 2017
Reverse phase protein microarrays advance to use in clinical trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
21 March 2017
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
7 April 2017
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
7 April 2017
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
7 April 2017
Rapid screening of novel agents for combination therapy in sarcomas
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Cell-based drug combination screening with a microfluidic droplet array system
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Polypill strategy for primary prevention of cardiovascular disorders
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Combinatorial drug screening identifies compensatory pathway interactions and adaptive resistance mechanisms
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Development of therapeutic combinations targeting major cancer signaling pathways
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Genotype-selective combination therapies for melanoma identified by high-throughput drug screening
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Combinatorial drug therapy for cancer in the post-genomic era.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Monitoring cleaved caspase-3 activity and apoptosis of immortalized oligodendroglial cells using live-cell imaging and cleaveable fluorogenic-dye substrates following potassium-induced membrane depolarization
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Challenges, successes and hopes in the development of novel TB therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Proof of concept: network and systems biology approaches aid in the discovery of potent anticancer drug combinations
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Functional proteomics to dissect tyrosine kinase signalling pathways in cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
The beautiful cell: high-content screening in drug discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
High-content phenotypic profiling of drug response signatures across distinct cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Antibody-based proteomics: analysis of signaling networks using reverse protein arrays
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Synergistic drug combinations tend to improve therapeutically relevant selectivity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
High-content screening: a new primary screening tool?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Multi-target therapeutics: when the whole is greater than the sum of the parts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 September 2017
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3389%2FFPHAR.2014.00118
retrieved
21 January 2018
Multidimensional drug profiling by automated microscopy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3389%2FFPHAR.2014.00118
retrieved
21 January 2018
Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.3389%2FFPHAR.2014.00118
retrieved
21 January 2018
Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive Inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4035564
retrieved
28 November 2018
FOLFIRINOX: from the ACCORD study to 2014
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24904421
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/24904421
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.3389/FPHAR.2014.00118
1 reference
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
PMC publication ID
4035564
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
PubMed publication ID
24904421
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4035564
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24904421%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 June 2020
ResearchGate publication ID
262931277
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
